Career History
| since 2026 | Senior Attending Physician in Anesthesiology, University Hospital of Zurich |
|---|---|
| 2025–2026 | Executive MBA (EMBA X), ETH Zurich and the University of St. Gallen (HSG) |
| 2025 | Medical Command for Major Incidents, Prehospital (SFG-P) – Lead Emergency Physician |
| 2024–2025 | Rotating Senior Physician in Cardiac Anesthesiology, University Children’s Hospital Zurich |
| 2024 | Diploma in Mountain Medicine and Diploma in Wilderness and Expedition Medicine |
| from 2022 to 2026 | Senior Physician in Cardiac Anesthesia and Critical Care Medicine, University Hospital of Zurich |
| 2022 | Specialist in intensive care medicine, University Hospital Zurich |
| 2022 | Specialist in anesthesiology, University Hospital Zurich |
| 2022 | Doctorate University of Zurich |
| 2020 | SGNOR Emergency physician |
| since 2019 | Instructor European Trauma Course ERC |
| since 2018 | Simulation Instructor (InPass) |
| 2019 – 2021 | Intensive Care Medicine, University Hospital Zurich |
| 2018 – 2019 | Internal Medicine, GZO Hospital Wetzikon |
| 2017 – 2018 | Helicopter doctor REGA |
| 2016 – 2017 | Anesthesia Cantonal Hospital Winterthur |
| 2015 – 2016 | Anesthesia Children’s Hospital Zurich |
| 2012 – 2015 | Anesthesia University Hospital Zurich |
| 2012 | Approbation |
Publications
Complete list of publications on PubMed
Original Works
- Gossler, T., Kaserer, A., Iten, M., & Akbas, S. (2026). Post-resuscitation care: From prehospital care to the intensive care unit. Emergency and Critical Care Medicine, 29(5), 421–431. https://doi.org/10.1007/s10049-026-01783-w
- Feiereisen, J., Boulos, R. E., Keskinaslan, C., Kalbas, Y., Pape, H.-C., Gossler, T., Milojevic, M., Tudorache, I., Risteski, P., Dzemali, O., & Rodriguez Cetina Biefer, H. (2026). Traumatic brain injury in patients with mechanical heart valves on lifelong anticoagulation: Incidence, management, and outcomes of intracranial hemorrhage. Frontiers in Cardiovascular Medicine, 13, Article 1874285. https://doi.org/10.3389/fcvm.2026.1874285
Conference Presentations
- Gossler, T., Deuse, T., Hua, X., Stubbendorff, M., Velden, J., Robbins, R. C., Reichenspurner, H., Michelakis, E., & Schrepfer, S. (February 12–15, 2012). Prevention, Inhibition, and Reversion of Chronic Allograft Vasculopathy Through Mitochondrial Modulation [Presentation V133]. 41st Annual Meeting of the German Society for Thoracic, Cardiac, and Vascular Surgery, Freiburg im Breisgau, Germany.
- Gossler, T., Ricklefs, F., Deuse, T., Masuda, E., Taylor, V., Park, G., Carroll, D., Reichenspurner, H., Robbins, R. C., & Schrepfer, S. (February 12–15, 2012). JAK3 inhibition: Suppressing immune cells while preserving epithelial cells [Presentation V248]. 41st Annual Meeting of the German Society for Thoracic, Cardiac, and Vascular Surgery, Freiburg im Breisgau, Germany.
- Hua, X., Deuse, T., Gossler, T., Stubbendorff, M., Haddad, F., Reichenspurner, H., Robbins, R. C., Michelakis, E., & Schrepfer, S. (February 12–15, 2012). Metabolic Modulation of Intimal Hyperplasia with Dichloroacetate [Presentation V131]. 41st Annual Meeting of the German Society for Thoracic, Cardiac, and Vascular Surgery, Freiburg im Breisgau, Germany.
- Hua, X., Boeddinghaus, J., Gossler, T., Stubbendorff, M., Deuse, T., Michelakis, E., Tsao, P. S., Maegdefessel, L., Erben, R., Reichenspurner, H., Robbins, R. C., & Schrepfer, S. (February 12–15, 2012). Translational models: A humanized model for studying the development of intimal hyperplasia after stenting [Presentation V134]. 41st Annual Meeting of the German Society for Thoracic, Cardiac, and
Vascular Surgery, Freiburg im Breisgau, Germany. - Hua, X., Gossler, T., Stubbendorff, M., Deuse, T., Taylor, V., Chen, Y., Reichenspurner, H., Robbins, R. C., & Schrepfer, S. (2011). Targeting the JAK1/3 pathway to suppress acute allograft rejection [Presentation, Abstract 276]. Transplant International, 24(Suppl. 3).
Poster Presentations
- Hua, X., Deuse, T., Stubbendorff, M., Gossler, T., Velden, J., Robbins, R. C., Michelakis, E., & Schrepfer, S. (2012). Role of Mitochondrial Activity in the Development of Chronic Allograft Vasculopathy [Abstract 352]. The Journal of Heart and Lung Transplantation, 31(4, Suppl.).
- Deuse, T., Hua, X., Stubbendorff, M., Gossler, T., Velden, J., Taylor, V., Park, G., Chen, Y., Reichenspurner, H., Robbins, R. C., & Schrepfer, S. (2012). The JAK1/3 inhibitor R507 reduces acute and chronic rejection while exhibiting immune cell specificity [Abstract 351]. The Journal of Heart and Lung Transplantation, 31(4, Suppl.).
- Deuse, T., Hua, X., Laenger, F., Gossler, T., Stubbendorff, M., Rakovic, A., Klein, C., Sutendra, G., Dromparis, P., Maegdefessel, L., Tsao, P. S., Velden, J., Reichenspurner, H., Robbins, R. C., Haddad, F., Michelakis, E., & Schrepfer, S. (2012). Pyruvate dehydrogenase kinase 2 controls vascular remodeling [Abstract 356]. The Journal of Heart and Lung Transplantation, 31(4, Suppl.).
- Zobel, T., Morozkina, N., Fechner, H., Schrepfer, S., Gossler, T., Weger, S., Becher, M., Schultheiss, H. P., Tschöpe, C., & Schmidt-Lücke, C. (2011). The nonstructural proteins NS1 and 11 kDa of human parvovirus B19 induce apoptosis via caspase 8 and 10, causing dysfunction in circulating cells with endothelial regenerative potential [Abstract 15187]. Circulation, 124(21, Suppl.).
- Deuse, T., Seifert, M., Phillips, N., Fire, A., Tsao, P. S., Volk, H. D., Hua, X., Gossler, T., Reichenspurner, H., Robbins, R. C., & Schrepfer, S. (2011). Immunobiology of naïve and genetically modified human embryonic stem cells with HLA-I knockdown [Abstract 16796]. Circulation, 124(21, Suppl.).
- Hua, X., Deuse, T., Gossler, T., Stubbendorff, M., Haddad, F., Reichenspurner, H., Michelakis, E., & Schrepfer, S. (2011). The mitochondrial K+ channel axis is involved in the development of intimal hyperplasia [Poster P026]. Transplant International, 24(Suppl. 3).
- Gossler, T., Hua, X., Stubbendorff, M., Deuse, T., Velden, J., Taylor, V., Chen, Y., Streichert, T., Reichenspurner, H., Robbins, R. C., & Schrepfer, S. (2011). Targeting the JAK1/3 pathway to suppress acute allograft rejection [Abstract 255]. The Journal of Heart and Lung Transplantation, 30(4, Suppl.).
- Gossler, T., Deuse, T., Masuda, E., Taylor, V., Park, G., Carroll, D., Reichenspurner, H., Velotta, J. B., Robbins, R. C., & Schrepfer, S. (2011). The JAK3 inhibitor R348 reduces acute and chronic rejection while exhibiting immune cell specificity [Abstract 256]. The Journal of Heart and Lung Transplantation, 30(4, Suppl.).
- Deuse, T., Gossler, T., Hua, X., Stubbendorff, M., Haddad, F., Velden, J., Reichenspurner, H., Robbins, R. C., Michelakis, E., & Schrepfer, S. (2011). Metabolic modulation—A Feasible Approach to Addressing Intimal Proliferation? [Abstract 400]. The Journal of Heart and Lung Transplantation, 30(4, Suppl.).
- Stubbendorff, M., Deuse, T., Hua, X., Gossler, T., Pahrmann, C., Tang-Quan, K. R., Reichenspurner, H., Robbins, R. C., & Schrepfer, S. (2011). Immunogenicity and Immunomodulatory Properties of Mesenchymal Stem Cells from the Umbilical Cord Lining for Regenerative Therapies [Abstract 545]. The Journal of Heart and Lung
Transplantation, 30(4, Suppl.). - Deuse, T., Gossler, T., Hua, X., Stubbendorff, M., Haddad, F., Reichenspurner, H., Robbins, R. C., Michelakis, E., & Schrepfer, S. (April 2011). Metabolic modulation—A Feasible Approach to Addressing Intimal Proliferation? [Conference paper]. 77th Annual Meeting of the German Society of Cardiology – Cardiovascular Research, Mannheim, Germany.
- Gossler, T., Deuse, T., Masuda, E., Taylor, V., Park, G., Carroll, D., Reichenspurner, H., Velotta, J. B., Robbins, R. C., & Schrepfer, S. (2010). Novel immunosuppression using the JAK3 inhibitor R348 [Abstract]. Transplant International, 23(Suppl.), 12.
- Gossler, T., Deuse, T., Weill, D., Reichenspurner, H., Robbins, R. C., & Schrepfer, S. (2010). Local immunosuppression through inhibition of NF-κB activation using inhaled tacrolimus [Abstract]. Transplant International, 23(Suppl.), 34.
- Gossler, T., Deuse, T., Weill, D., Reichenspurner, H., Robbins, R. C., & Schrepfer, S. (October 2010). Inhaled tacrolimus to suppress the local immune response [conference abstract]. AST & ESOT Joint Meeting, Nice, France.
More Articles
- Gossler, T., & Schrepfer, S. (2011). JAK-1/3 inhibition to prevent acute organ rejection. MedReport, 35(31).
Memberships
- FMH (Foederatio Medicorum Helveticorum – Association of Swiss Physicians)
- SACTA (Swiss Association of Cardiovascular and Thoracic Anesthesia)
- SGI (Swiss Society for Intensive Care Medicine)
- VSAO (Association of Swiss Resident Physicians and Senior Physicians)
- ZGI (Zurich Society for Intensive Care Medicine)